|本期目录/Table of Contents|

[1]刘 明,崔恩博,贾天野,等.肝病患者细菌性血流感染的临床与实验室特点分析[J].传染病信息,2018,04:352-355367.
 LIU Ming,CUI En-bo,JIA Tian-ye,et al.Analysis of clinical and experimental characteristics of bacterial bloodstream infections in patients with liver diseases[J].Infectious Disease Information,2018,04:352-355367.
点击复制

肝病患者细菌性血流感染的临床与实验室特点分析(PDF)

《传染病信息》[ISSN:1007-8134/CN:11-3886/R]

期数:
2018年04期
页码:
352-355367
栏目:
论 著
出版日期:
2018-08-30

文章信息/Info

Title:
Analysis of clinical and experimental characteristics of bacterial bloodstream infections in patients with liver diseases
作者:
刘 明崔恩博贾天野陈素明张树永鲍春梅曲 芬
100039 北京,解放军第三〇二医院临床检验医 学中心(刘明、崔恩博、贾天野、陈素明、张树永、鲍春梅、 曲芬)
Author(s):
LIU Ming CUI En-bo JIA Tian-ye CHEN Su-ming ZHANG Shu-yong BAO Chun-mei QU Fen*
Clinical Laboratory Centre, 302 Military Hospital of China, Beijing 100039, China
关键词:
血流感染临床特征实验特征耐药率
Keywords:
bloodstream infections clinical characteristics experimental characteristics drug resistance rate
分类号:
R631 
DOI:
10.3969/j.issn.1007-8134.2018.04.013
文献标识码:
A
摘要:
目的 探讨肝病患者细菌性血流感染的临床及实验特点,为临床早期治疗提供依据。方法 回顾性分析 2016 年1 月1 日—12 月31 日期间本院住院肝病患者诊断为血流感染的病历资料,总结患者的临床特征,并比较革兰阴性 菌和革兰阳性菌在临床特征、微生物学特征、其他感染指标变化的差异。结果 在425 例单菌种血流感染病原菌中,院内 感染患者309 例(72.71%),以革兰阴性菌为主(53.18%)。细菌性血流感染患者主要临床表现包括发热(90.59%)、寒 战(40.47%)、感染性休克(17.18%)。革兰阴性菌感染组发热、寒战、休克及腹膜炎的发生率均明显高于革兰阳性 菌感染组(P 均< 0.05)。其他感染指标比较,革兰阴性菌感染组在CRP、降钙素原、WBC 及中性粒细胞百分比的 升高程度均高于革兰阳性菌感染组(P 均< 0.05)。革兰阴性菌对抗菌药物的耐药率以氨苄西林最高,为80.50%,其 次为复方新诺明(34.47%)和氨苄西林/ 舒巴坦(33.70%),耐药率较低的包括亚胺培南(3.40%)、美罗培南(2.50%) 和阿米卡星(2.00%);革兰阳性菌对抗菌药物的耐药率以红霉素最高,为73.27%,其次为青霉素(65.64%)和苯唑 西林(57.00%),对万古霉素、利奈唑胺和替加环素均无耐药菌株。结论 细菌性血流感染病原菌以革兰阴性菌为主, 其临床表现更严重,辅助感染指标异常变化程度更高。临床应结合血流感染的临床及实验特征,早期经验用药,提高 救治率。   
Abstract:
Objective To investigate the clinical and experimental characteristics of bacterial bloodstream infections in patients with liver diseases and provide evidence for early clinical treatment. Methods A retrospective analysis was conducted to analyze the medical records of inpatients with the diagnosed bloodstream infection in our hospital from 1 January 2016 to 31 December 2016. The clinical characteristics of infected patients were summarized, and the differences of clinical features, microbiological characteristics and other infectious indicators between gram negative bacteria and gram positive bacteria in infected patients were compared. Results Among 425 cases of single strain bloodstream infections, 309 (72.71%) cases were diagnosed as nosocomial infection and 53.18% of them were infected with gram negative bacteria. The main clinical manifestations of patients with bacterial bloodstream infections included fever (90.59%), chills (40.47%) and septic shock (17.18%). The incidences of fever, chills, shock and peritonitis in gram negative bacteria group were significantly higher than those in gram positive bacteria group (P < 0.05). Compared with other infection indicators, the increments of CRP, procalcitonin, WBC and percentage of neutrophil cells in gram negative bacteria infection group were higher than those in gram positive bacteria infection group (P < 0.05). The highest resistance rate to antibiotics in gram negative bacteria was found in ampicillin (80.50%), followed by SMZ-TMP (34.47%) and ampicillin/sulbactam (33.70%). The lower resistance rates to antibiotics were found in imipenem (3.40%), meropenem (2.50%) and amikacin (2.00%). The resistance rate to antibiotics in gram positive bacteria was the highest in erythromycin (73.27%), followed by penicillin (65.64%) and oxacillin (57.00%), and absent in vancomycin, linezolid and tigecycline. Conclusions Gram negative bacteria are the main pathogens of bacterial bloodstream infections with more serious clinical manifestations and higher abnormal levels of auxiliary infection indicators. Patients should be treated by early empirical medication and the survival rate is improved according to clinical and experimental characteristics of bloodstream infections.  

参考文献/References


[1] Edmond MB,Wallace SE, McClish DK, et al. Nosocomial bloodstream infections in United States hospitals: a three-year analysis[J]. Clin Infect Dis, 1999, 29(2):239-244.
[2] 杨祖耀,詹思延,王波, 等. 中国血流感染住院病死率的系 统评价和meta 分析[J]. 北京大学学报(医学版),2010, 42(3):304-307.
[3] Kaukonen KM, Bailey M, Suzuki S, et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012[J]. JAMA, 2014, 311(13):1308- 1316.
[4] Fleischmann C, Scherag A, Adhikari NK, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations[J]. Am J Respir Crit Care Med, 2016, 193(3):259-272.
[5] Suarez De La Rica A, Gilsanz F, Maseda E. Epidemiologic trends of sepsis in western countries[J]. Ann Transl Med, 2016, 4(17):325.
[6] Liao X, Du B, Lu M, et al. Current epidemiology of sepsis in mainland China[J]. Ann Transl Med, 2016, 4(17):324.
[7] Weng L, Zeng XY, Yin P, et al. China Critical Care Clinical Trials Group (CCCCTG). Sepsis-related mortality in China: a descriptive analysis[J]. Intensive Care Med, 2018, 44(7):1071-1080.
[8] Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock[J]. Crit Care Med, 2006, 34(6):1589-1596.
[9] Kim KE,Han JY. Evaluation of the clinical performance of an automated procalcitonin assay for the quantitative detection of blood stream infection [J]. Korean J Lab Med, 2010, 30(2):153-159.
[10] 张有江,王欢,罗艳萍,等. 定量降钙素原测定在血流感染 诊断中的应用[J]. 军医进修学院学报,2010,31(12):1219- 1221.
[11] Busl KM. Nosocomial infections in the neurointensive care unit[ J]. Neurol Clin, 2017, 35 (4):785-807.
[12] CLSI. Performance standards for antimicrobial susceptibility testing: twenty-fifth informational supplement. CLSI document M100-S25[S]. Wayne, PA: CLSI, 2015.
[13] Skogberg K, Lyytik.inen O, Ollgren J, et al. Population-based burden of bloodstream infections in Finland[J]. Clin Microbiol Infect, 2012, 18(6):E170-E176.
[14] 陈素明,崔恩博,熊艺茹,等. 1405 例肝硬化并发败血症病原 特点及预后分析[J]. 传染病信息,2014,27(3):148-151.
[15] Askarian M, Yadollahi M, Assadian O. Point prevalence and risk factors of hospital acquired infections in a cluster of universityaffiliated hospitals in Shiraz, Iran[J]. J Infect Public Health, 2012, 5(2):169-176.
[16] Putker F, Bos MP, Tommassen J. Transport of lipopolysaccharide to the Gram-negative bacterial cell surface[J]. FEMS Microbiol Rev, 2015, 39(6):985-1002.
[17] Liu CY, Liao CH, Chen YC, et al. Changing epidemiology of nosocomial bloodstream infections in 11 teaching hospitals in Taiwan between 1993 and 2006[J]. J Microbiol Immunol Infect, 2010, 43(5):416-429.
[18] 徐定华,石秋萍,王超,等. 降钙素原在感染性疾病诊断 中应用价值的临床病例分析[J]. 临床和实验医学杂志, 2014,13(8):679-681.
[19] Papadimitriou-Olivgeris M, Marangos M. Christofidou M, et al. Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit[J]. Scand J Infect Dis, 2014, 46(9):642- 648.
[20] Carrol ED, Mankhambo LA, Jeffers G, et al. The diagnostic and prognostic accuracy of five markers of serious bacterial infection in Malawian children with signs of severe infection[J]. PLoS One, 2009, 4(8):e6621.
[21] Tang J, Long W, Yan L, et al. Procalcitonin guided antibiotic therapy of acute exacerbations of asthma:a randomized controllde trial[J]. BMC Infect Dis, 2013, 13(1):596.
[22] Loonen AJ, de Jager CP, Tosserams JA, et al. Biomarkers and molecular analysis to improve bloodstream infection diagnostics in an emergency care unit [J]. PLoS One, 2014, 9(1):e87315.
[23] Titova E, Christensen A, Henriksen AH, et al. Comparison of procalcitonin, C-reactive protein, white blood cell count and clinical status in diagnosing pneumonia in patients hospitalized with acute exacerbations of COPD: A prospective observational study[J]. Chron Respir Dis, 2018 Jan [Epub ahead of print]. DOI: 10.1177/1479972318769762
[24] 王滩枫,席云, 钟月桂. 血培养中病原菌分布及药敏调查分 析[J]. 中国微生态学杂志,2010,22(10):918-921.
[25] 乔亚峰,叶振东,张国雄,等. 血培养常见病原菌的分布及 耐药性分析 [J]. 实验与临床医学,2011,29(2):136-137.
[26] 胡月,王宇,刘景院,等. 血培养常见病原菌的分布及耐药 性分析[J]. 传染病信息,2018,30(1):71-74.
[27] Daikos GL, Markogiannakis A, Souli M, et al. Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae:a clinical perspective[J]. Expert Rev Anti Infect Ther, 2012, 10(12):1393-1404.
[28] Nasa P, Juneja D, Singh O, et al. An observational study on bloodstream extended-spectrum beta-lactamase infection in critical care unit:incidence, risk factors and its impact on outcome [J]. Eur J Int Med, 2012, 23(2):192-195.

备注/Memo

备注/Memo:
[ 基金项目 ] 北京市科学技术委员会首都市民健康培训项目 (Z151100003915151) [ 作者单位] 100039 北京,解放军第三〇二医院临床检验医 学中心(刘明、崔恩博、贾天野、陈素明、张树永、鲍春梅、 曲芬) [ 通信作者] 曲芬,E-mail: qf302@163.com
更新日期/Last Update: 2018-09-08